The dawn of a new era for nonalcoholic fatty liver disease?

Non-alcoholic fatty liver disease(NAFLD)has become the most frequent chronic liver disease in several developed and developing countries,affecting roughly 30%of adults in the general population,65-70%of individuals with type 2 diabetes mellitus and,virtually,all patients with obesity(1).Of note,its prevalence is believed to rise dramatically over the next decade,along with an increase of prevalence in obesity,diabetes mellitus and metabolic syndrome.